Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bayer Aktienges ADR (OP: BAYRY )

7.840 +0.220 (+2.89%)
Streaming Delayed Price Updated: 3:27 PM EDT, Sep 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 213,419
Open 7.750
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 7.620
Today's Range 7.720 - 7.890
52wk Range 6.820 - 13.19
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bayer Targets Expanded Use Approval For Prostate Cancer Drug, Reveals Encouraging Data From Pivotal Study
Bayer's Phase 3 ARANOTE trial showed darolutamide plus androgen deprivation therapy (ADT) reduced the risk of radiological progression or death in metastatic hormone-sensitive prostate cancer patients... 
Via Benzinga
Roivant Sciences Unveils New 'Vant' Subsidiary For In-Licensed Pulmonary Hypertension Drug From Bayer
Roivant Sciences has licensed worldwide rights to develop and commercialize Bayer's mosliciguat for an upfront payment of $14 million and up to $280 million in future milestone payments. 
Via Benzinga

Performance

YTD
-16.42%
-16.42%
1 Month
-2.73%
-2.73%
3 Month
+11.21%
+11.21%
6 Month
+12.14%
+12.14%
1 Year
-39.69%
-39.69%

More News

Read More
Why Is BridgeBio Pharma Stock Trading Higher On Friday?
Via Benzinga
BAYRY Stock Earnings: Bayer Meets EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Bayer Weedkiller Lawsuit Dismissed By Australian Judge: Insufficient Evidence Linking Roundup To Blood Cancer
Via Benzinga
Topics Lawsuit
Exposures Financial Glyphosate Legal
ScottsMiracle-Gro Stock Blooms After Investor Day Optimism
Via MarketBeat
Topics Cannabis
Exposures Cannabis
3 Longevity Stocks to Buy for Anti-Aging Breakthroughs
Via InvestorPlace
3 Small-Cap Stocks With Explosive 2X Growth Potential
Via InvestorPlace
Judge Slashes Bayer's Massive $2B Roundup Verdict To $400M
Via Benzinga
Exposures Glyphosate
Week In Review: MediLink And BioNTech Form $1.8 Billion ADC Partnership
Via Talk Markets
European Equities Close Higher As Traders Bank On Imminent ECB Rate Cut: What's Driving Markets Monday?
Via Benzinga
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
Via Benzinga
Topics Data Breach
Exposures Information Security
Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
Via Benzinga
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Via Benzinga
BAYRY Stock Earnings: Bayer Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
From Hype To Reality, AI Reshapes Pharmaceutical Industry Across Drug Discovery To Marketing - Stocks To Watch
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Bayer's Monsanto Scores Legal Victory as $185M Verdict Overturned
Via Benzinga
Exposures Glyphosate
Alphabet, Nasdaq, Spotify, Teck Resources And A Major Financial Stock On CNBC's 'Final Trades'
Via Benzinga
Google Partners With European Conglomerate Bayer For New AI-Powered Solutions For Radiologists
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Wondering Where To Find An Over 7% Annual Return? Check Out These 10 Investment-Grade Corporate Bonds
Via Benzinga
Topics Bonds
Exposures Debt Markets
Bayer-Backed Boundless Bio Falls After IPO
Via Talk Markets
Dyadic Intl. Inc. (NASDAQ: DYAI) Potential Strategic Alliances with Future of Foods Boosts Stock as Key Conference Looms
Via AB Newswire
Topics Supply Chain
Exposures Supply Chain
Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant
Via Benzinga
Exposures Product Safety
German Conglomerate Bayer Goes Johnson & Johnson Way To Tackle Its Cancer Related Lawsuits
Via Benzinga
Topics Bankruptcy Lawsuit
Exposures Financial Glyphosate Legal
BAYRY Stock Earnings: Bayer Beats EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.